Here are three things to know:
1. Baxter Ventures, the venture investment arm of Baxter International, led the funding round. Other investors included Summation Health, CWC HealthTech Advisors and Stanford-StartX Fund.
2. The funding will accelerate the availability of Prescient Surgical’s CleanCision therapy, which targets the sources of surgical site infection.
3. SSI, particularly in abdominal surgery, poses a significant threat to patient safety. An estimated 15 percent of patients undergoing high-risk abdominal surgery will develop an SSI.
More articles on quality:
Can electronic monitoring systems improve hand hygiene? 4 study findings
6 ways ASCs can optimize patient satisfaction
How Andrews Institute Ambulatory Surgery Center cut flash sterilization episodes from 2.4K to 0
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
